最新の特集記事
The Power and Promise of Liquid Biopsies
By: Dr. Phil Febbo, Chief Medical Officer at Illumina
特集記事
New Liquid Biopsy and High-Throughput Assays Join TruSight Oncology Portfolio
Provides customers the capability to run blood and tissue samples on the NovaSeq 6000 Sequencing System
Texas A&M Deploys DRAGEN
First American Academic Institution Install for Agricultural Applications
The Genetics of Halloween
What lurks in the genome may surprise and someday, help you
Fighting For My Life, I Also Fought For Yours
By: Sandra Balladares, Ph.D., Global Marketing Manager at Illumina
Press Releases
In the News
| 日付 | 論文 | タイトル |
|---|---|---|
| 2019/10/16 | NPR | A Boy's Mysterious Illness Leads His Family On A Diagnostic Odyssey |
| 2019/10/09 | Yahoo! Finance | Illumina Inks Deal to Commercialize NGS-Based IVD Kits |
| 2019/09/30 | ClinicalOMICs | Illumina and the Broad Co-Developing Open-Source Secondary Analysis Software |
| 2019/08/30 | WIRED | One Scientist’s Quest to Bring DNA Sequencing to Every Sick Kid |
| 2019/08/29 | Chasing the Cure | Debra and Delaney Found Their Diagnosis |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.